CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Option exercise 10% owner acquired 463,298 shares (option exercise)
- 8-K Event Regulation FD disclosure
- 4/A Option exercise Director acquired 5,021 shares (option exercise)
- 4 Option exercise President and CEO acquired 7,531 shares (option exercise)
- 4 Option exercise Director acquired 11,250 shares (option exercise)
- 4 Option exercise Director acquired 5,021 shares (option exercise)
- 8-K Event Regulation FD disclosure
- 4 Option exercise Director acquired 5,210 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- 8-K Event Results of operations
Page 25 of 78 · 1,549 filings